ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for charts 登録してリアルタイムのチャート、分析ツール、価格を入手してください。

ELEV Elevation Oncology Inc

3.7061
-0.3039 (-7.58%)
2024年4月20日 - 終了
15分遅延
名称 銘柄コード 市場 種別
Elevation Oncology Inc ELEV NASDAQ 普通株式
  前日比 前日比 % 現在値 時刻
-0.3039 -7.58% 3.7061 09:00:00
始値 安値 高値 終値 前日終値
4.00 3.75 4.07 3.80 4.01
この銘柄の詳細情報 »

最新ニュース

日付 時間 ソース タイトル
2024/4/0905:30PRNUSElevation Oncology Presents Preclinical Proof-of-Concept..
2024/3/0622:14EDGAR2Form S-8 - Securities to be offered to employees in employee..
2024/3/0621:45EDGAR2Form 8-K - Current report
2024/3/0621:30PRNUSElevation Oncology Reports Fourth Quarter and Full Year 2023..
2024/3/0621:00EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
2024/3/0606:50PRNUSElevation Oncology to Present Preclinical Proof-of-Concept..
2024/3/0506:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/3/0506:21EDGAR2Form 3 - Initial statement of beneficial ownership of..
2024/3/0421:30PRNUSElevation Oncology Appoints Experienced Clinical Development..
2024/2/2821:30PRNUSElevation Oncology to Participate in Upcoming Investor..
2024/2/2221:30PRNUSElevation Oncology Expands Ongoing Phase 1 Clinical Trial of..
2024/2/2107:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/2106:57EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/2106:52EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/1506:45EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
2024/1/2406:15EDGAR2Form 8-K - Current report
2024/1/2306:57EDGAR2Form SC 13G - Statement of acquisition of beneficial..
2024/1/2306:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/1/2306:24EDGAR2Form 3 - Initial statement of beneficial ownership of..
2024/1/2221:45EDGAR2Form 8-K - Current report
2024/1/2221:30PRNUSElevation Oncology Announces Appointment of Darcy Mootz,..
2024/1/1006:24EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
2024/1/0521:40EDGAR2Form 8-K - Current report
2024/1/0521:30PRNUSElevation Oncology Announces Program Updates and Upcoming..
2023/11/2221:30PRNUSElevation Oncology to Present at the Piper Sandler 35th..
2023/11/0220:45EDGAR2Form 8-K - Current report
2023/11/0220:30PRNUSElevation Oncology Reports Third Quarter 2023 Financial..
2023/11/0220:00EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/9/2305:30EDGAR2Form 8-K - Current report
2023/9/0520:30PRNUSElevation Oncology to Present at the H.C. Wainwright 25th..
2023/8/1620:45EDGAR2Form 8-K - Current report
2023/8/1620:30PRNUSElevation Oncology Announces First Patient Dosed in the..
2023/8/0320:45EDGAR2Form 8-K - Current report
2023/8/0320:30PRNUSElevation Oncology Reports Second Quarter 2023 Financial..
2023/8/0320:15EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
2023/8/0320:01EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/7/1505:29EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/7/1505:26EDGAR2Form 3 - Initial statement of beneficial ownership of..
2023/7/1321:15EDGAR2Form 8-K - Current report
2023/7/1321:00PRNUSElevation Oncology Appoints Joseph Ferra as Chief Executive..
2023/6/0911:41PRNUSElevation Oncology Announces Pricing of $50 Million Public..
2023/6/0905:01PRNUSElevation Oncology Announces Launch of Proposed Public..
2023/6/0322:00PRNUSElevation Oncology Highlights First-in-Human Phase 1..
2023/5/1520:30PRNUSElevation Oncology Reports First Quarter 2023 Financial..
2023/4/2705:05PRNUSElevation Oncology Highlights Clinical Data for SYSA1801..

最近閲覧した銘柄

Delayed Upgrade Clock